NYSE · Financial Statements

Pediatrix Medical Group, Inc. (MD) Financial Statements

$29.29 NYSE: MD Market Cap $2.38B

Pediatrix Medical Group, Inc. most recently reported annual revenue of $1.9B, net profit of $165.0M. Revenue grew at an average annual rate of 2.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Pediatrix Medical Group, Inc.: Revenue fell from $3.2B in 2016 to $1.9B in 2025, a change of -39.9% over 9 years; net profit was positive in 6 of 10 reported years; operating margin moved from 18.0% to 12.1%, a shift of -5.9 percentage points; the most recent year shows net profit of $165.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$3.2B$3.5B$3.6B$1.8B$1.7B$1.9B$2.0B$2.0B$2.0B$1.9B
Operating Expenses$2.6B$3.0B$3.2B$1.6B$1.6B$1.7B$1.8B$2.0B$2.1B$1.7B
Operating Profit$572.0M$480.0M$446.0M$172.0M$98.0M$203.0M$173.0M$7.0M$-69.0M$231.0M
Operating Margin18.0%13.9%12.2%9.7%5.7%10.6%8.8%0.4%-3.4%12.1%
Other Income$-58.0M$-70.0M$120.0M$-113.0M$-91.0M$-68.0M$-91.0M$-56.0M$-33.0M$-15.0M
Interest$63.0M$75.0M$93.0M$119.0M$110.0M$69.0M$40.0M$42.0M$41.0M$36.0M
Depreciation$89.0M$103.0M$84.0M$26.0M$28.0M$32.0M$36.0M$36.0M$32.0M$22.0M
Profit Before Tax$514.0M$410.0M$369.0M$59.0M$7.0M$135.0M$81.0M$-48.0M$-101.0M$216.0M
Tax$36.8M$21.9M$27.2M$28.2M$234.0M$20.1M$23.1M$-24.9M$2.2M$23.6M
Net Profit$325.0M$320.0M$269.0M$-1.5B$-796.0M$131.0M$66.0M$-60.0M$-99.0M$165.0M
EPS$3.47$3.42$2.93$-17.94$-9.55$1.52$0.79$-0.73$-1.19$1.94
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$507.0M$496.0M$495.0M$504.0M$511.0M$502.0M$458.0M$469.0M$493.0M$494.0M$476.0M$488.0M
Operating Expenses$466.0M$608.0M$479.0M$662.0M$477.0M$463.0M$426.0M$409.0M$425.0M$439.0M$430.0M$431.0M
Operating Profit$40.0M$-111.0M$16.0M$-158.0M$34.0M$39.0M$32.0M$60.0M$68.0M$55.0M$47.0M$57.0M
Operating Margin8.0%-22.5%3.2%-31.3%6.6%7.8%7.0%12.8%13.8%11.1%9.8%11.7%
Interest$10.0M$10.0M$11.0M$10.0M$10.0M$10.0M$9.0M$9.0M$3.0M$9.0M$8.0M$8.0M
Profit Before Tax$31.0M$-139.0M$8.0M$-168.0M$25.0M$33.0M$28.0M$55.0M$88.0M$46.0M$39.0M$54.0M
Tax$30.6M$10.5M$48.4M$8.8M$23.0M$8.6M$26.2M$28.6M$18.3M$26.1M$23.9M$26.2M
Net Profit$21.0M$-124.0M$4.0M$-153.0M$19.0M$30.0M$21.0M$39.0M$72.0M$34.0M$30.0M$40.0M
EPS$0.26$-1.50$0.05$-1.84$0.23$0.35$0.24$0.45$0.84$0.40$0.36$0.49

Over the 10 years reported for Pediatrix Medical Group, Inc., borrowings decreased from $1.7B in 2016 to $660.0M in 2025, cash stood at $375.0M in the latest year, shareholders' equity was $1.0M, current assets covered current liabilities 1.66 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$5.3B$5.9B$5.9B$4.1B$3.3B$2.7B$2.3B$2.2B$2.2B$2.2B
Current Assets$587.0M$627.0M$657.0M$732.0M$1.5B$841.0M$428.0M$483.0M$640.0M$764.0M
Cash$56.0M$60.0M$37.0M$108.0M$1.1B$387.0M$10.0M$73.0M$230.0M$375.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$495.0M$504.0M$507.0M$434.0M$242.0M$316.0M$297.0M$280.0M$273.0M$242.0M
Fixed Assets$103.0M$124.0M$133.0M$129.0M$132.0M$136.0M$140.0M$146.0M$78.0M$74.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$90.0M$91.0M$92.0M$75.0M$105.0M$100.0M$93.0M$104.0M$119.0M$145.0M
Other Assets$4.1B$4.6B$4.7B$1.5B$1.5B$1.5B$1.5B$1.4B$1.2B$1.3B
Total Liabilities$2.6B$2.8B$2.8B$2.6B$2.6B$1.8B$1.5B$1.4B$1.4B$1.4B
Current Liabilities$408.0M$438.0M$469.0M$542.0M$444.0M$427.0M$427.0M$389.0M$434.0M$459.0M
Borrowings$1.7B$1.9B$2.0B$1.8B$1.8B$1.1B$717.0M$702.0M$662.0M$660.0M
Other Liabilities$873.0M$948.0M$872.0M$854.0M$796.0M$760.0M$739.0M$669.0M$725.0M$721.0M
Equity$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Reserves$2.8B$3.1B$3.1B$1.5B$747.0M$896.0M$892.0M$849.0M$765.0M$866.0M

For Pediatrix Medical Group, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $253.0M; free cash flow was positive in 10 of 10 years; financing activities used $90.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$444.0M$511.0M$290.0M$358.0M$205.0M$77.0M$167.0M$137.0M$207.0M$271.0M
Investing Cash Flow$-880.0M$-626.0M$-210.0M$83.0M$787.0M$-85.0M$-87.0M$-82.0M$-57.0M$-37.0M
Financing Cash Flow$-68.0M$-56.0M$-300.0M$-165.0M$-10.0M$-4.0M$-88.0M$-12.0M$-3.0M$-90.0M
Net Cash Flow$4.0M$25.0M$-23.0M$67.0M$1.0B$-736.0M$-378.0M$63.0M$157.0M$145.0M
Free Cash Flow$405.0M$462.0M$241.0M$338.0M$176.0M$44.0M$137.0M$104.0M$185.0M$253.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.19
EV / EBITDA9.23
FCF Yield10.74%
Quick Ratio1.32
Interest Coverage8.01
Return 1Y102.75%
Return 3Y82.80%
Return 5Y-10.13%

Pediatrix Medical Group, Inc. (MD) financials — frequently asked questions

What is Pediatrix Medical Group, Inc.'s annual revenue?

Pediatrix Medical Group, Inc. (MD) reported annual revenue of $1.9B in its most recent fiscal year.

What is Pediatrix Medical Group, Inc.'s net profit?

Pediatrix Medical Group, Inc. (MD) reported net profit of $165.0M in its most recent fiscal year.

What is MD EV/EBITDA?

Pediatrix Medical Group, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 9.23.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
MD Overview MD Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.